v3.26.3
UNAUDITED INTERIM CONDENSED STATEMENTS OF COMPREHENSIVE LOSS
₩ in Thousands
 3 Months Ended 6 Months Ended 12 Months Ended
Dec. 31, 2024
USD ($)
$ / shares
shares
Jun. 30, 2026
USD ($)
$ / shares
shares
Jun. 30, 2026
KRW (₩)
₩ / shares
shares
Jun. 30, 2025
USD ($)
$ / shares
shares
Jun. 30, 2025
KRW (₩)
₩ / shares
shares
Dec. 31, 2025
USD ($)
$ / shares
shares
Dec. 31, 2025
KRW (₩)
₩ / shares
shares
Dec. 31, 2024
KRW (₩)
₩ / shares
shares
Revenues                
Revenue | $        
Total revenues | $        
Cost of revenues | $        
Gross profit | $        
Selling, general and administrative expenses | $ 30,000     7,725    
Total operating cost and expenses | $ 30,000     7,725    
Operating loss | $ (30,000)     (7,725)    
Interest income | $ 618 1,140   1,140   2,300    
Interest expense | $ (371) (684)   (684)   (1,380)    
Loss for the period | $ (29,753) 456   456   (6,805)    
Other comprehensive income                
Total comprehensive loss for the period | $ $ (29,753) $ 456   $ 456   $ (6,805)    
Weighted average number of shares of common stock outstanding, basic and diluted | shares 50,000 50,000 50,000 50,000 50,000 50,000 50,000  
Basic loss per share | (per share) $ (0.60) $ 0.01 ₩ 0.01 $ 0.01 ₩ 0.01 $ (0.14) ₩ (0.14)  
Diluted loss per share | (per share) $ (0.60) $ 0.01 ₩ 0.01 $ 0.01 ₩ 0.01 $ (0.14) ₩ (0.14)  
CubeBio Co., Ltd. [Member]                
Revenues                
Revenue        
Total revenues        
Cost of revenues        
Gross profit        
Selling, general and administrative expenses     (2,965,749)   (3,350,674)   (5,781,058) (7,449,087)
Other income     290,384   685   191,076 525,695
Other expenses     (83,262)   (93,828)   (373,378) (677,439)
Operating loss     (2,758,627)   (3,443,817)   (5,963,360) (7,600,831)
Finance income     235,798   450,881   698,329 876,504
- Related parties     9,961   4,122   9,716 24,374
- Non-related parties     225,837   446,759   688,613 852,130
Finance costs     (475,066)   (407,245)   (876,445) (1,341,007)
- Related parties     (11,973)   (4,509)   (6,789) (321,827)
- Non-related parties     (463,093)   (402,736)   (869,656) (1,019,180)
Loss before income tax     (2,997,895)   (3,400,181)   (6,141,476) (8,065,334)
Income tax expenses        
Loss for the period     (2,997,895)   (3,400,181)   (6,141,476) (8,065,334)
Other comprehensive income                
Remeasurement of defined benefit liabilities             52,121 (127,853)
Total comprehensive loss for the period     ₩ (2,844,163)   ₩ (3,374,120)   ₩ (6,089,355) ₩ (8,193,187)
Loss per share (in Korean won)   (61 (61 (70 (70      
Weighted average number of shares of common stock outstanding, basic and diluted | shares   48,983,401 48,983,401 48,363,837 48,363,837 48,630,571 48,630,571 45,225,519
Basic loss per share | ₩ / shares     ₩ (61)   ₩ (70)   ₩ (126) ₩ (178)
Diluted loss per share | ₩ / shares     ₩ (61)   ₩ (70)   ₩ (126) ₩ (178)